陽普醫療(300030.SZ):兩項醫療器械產品獲得延續註冊
格隆匯12月2日丨陽普醫療(300030.SZ)公佈,近日,公司收到了由廣東省藥品監督管理局頒發2項的《醫療器械註冊證》。
其中,產品名稱:促黃體生成素排卵檢測儀(型號、規格:Z1);註冊證有效期:2021年11月25日-2027年3月13日;註冊分類:Ⅱ類;預期用途/適用範圍:該儀器與配套的促黃體生成素檢測試劑(熒光定量免疫層析法)配合使用,供家庭個人監測尿液中促黃體生成素濃度的變化。
產品名稱:促黃體生成素測定試劑(熒光定量免疫層析法);註冊證有效期:2021年11月17日-2027年3月31日;註冊分類:Ⅱ類;預期用途/適用範圍:該試劑用於定量檢測婦女尿液中促黃體生成激素(LH)水平,以預測排卵時間,用於指導育齡婦女選擇最佳受孕時機。
上述產品獲得延續註冊,將能保障該類產品的持續銷售,使公司促黃體生成素排卵檢測儀(Z1)產品及其配套的促黃體生成素測定試劑(熒光定量免疫層析法)在市場上擁有持續競爭力,對公司未來經營將產生積極的正面影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.